HAEMATO Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Patrick Brenske

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure11.2yrs

Recent management updates

Recent updates


CEO

Patrick Brenske

2.5yrs

Tenure

Mr. Patrick Brenske has been Chief Executive Officer of MPH Health Care AG (formerly known as MPH Mittelständische Pharma Holding AG) since January 23, 2009 and has been its Member of Management Board sinc...


Board Members

NamePositionTenureCompensationOwnership
Sabine Meck
Deputy Chairwoman of the Supervisory Board16.6yrsno datano data
Andrea Grosse
Chairwoman of the Supervisory Board11.2yrsno datano data
Uwe Zimdars
Member of Supervisory Board3.3yrsno datano data

11.2yrs

Average Tenure

Experienced Board: 0VZ7's board of directors are seasoned and experienced ( 11.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/08 10:51
End of Day Share Price 2024/04/10 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HAEMATO AG is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward AcklinFirst Berlin Equity Research GmbH
Cosmin FilkerGBC AG
Christian EhmannWarburg Research GmbH